These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17725297)

  • 1. [A preliminary study of contrast-enhanced ultrasound in benign prostatic hyperplasia].
    Tang J; Wang ZL; Li JL; Luo YK; Wang W; Xu JH; Shi HY
    Zhonghua Nan Ke Xue; 2007 Jul; 13(7):584-7. PubMed ID: 17725297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced transrectal ultrasound for assessing vascularization of hypoechoic BPH nodules in the transition and peripheral zones: comparison with pathological examination.
    Yang JC; Tang J; Li Y; Fei X; Shi H
    Ultrasound Med Biol; 2008 Nov; 34(11):1758-64. PubMed ID: 18524461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia.
    Shi J; Yin X; Xu R; Wang Y; Jin L; Gao W
    Diagn Pathol; 2014 Jul; 9():133. PubMed ID: 24986664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative morphometry of hyperplastic hypoechoic nodules in the prostatic outer gland].
    Li X; Wang N; Shi HY; Zhang Y; Fu XS; Li JL; Xu JH; Tang J
    Zhonghua Nan Ke Xue; 2005 Feb; 11(2):91-3. PubMed ID: 15755023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasonographic characteristics of the diseased canine prostate gland.
    Troisi A; Orlandi R; Bargellini P; Menchetti L; Borges P; Zelli R; Polisca A
    Theriogenology; 2015 Nov; 84(8):1423-30. PubMed ID: 26277703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction.
    Berger AP; Deibl M; Leonhartsberger N; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer AE; Bartsch G; Frauscher F
    BJU Int; 2005 Nov; 96(7):1073-8. PubMed ID: 16225531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement characteristics of benign and malignant focal peripheral nodules in the peripheral zone of the prostate gland studied using contrast-enhanced transrectal ultrasound.
    Tang J; Yang JC; Luo Y; Li J; Li Y; Shi H
    Clin Radiol; 2008 Oct; 63(10):1086-91. PubMed ID: 18774354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate zones in three-dimensional transrectal ultrasound.
    Strasser H; Janetschek G; Reissigl A; Bartsch G
    Urology; 1996 Apr; 47(4):485-90. PubMed ID: 8638355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bi-planar transrectal ultrasonographic study on the diagnosis of hyperplasia prostate gland].
    Que YH; Wang XM
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):191-4. PubMed ID: 15804110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between prostatic parameters of transrectal ultrasonography and age in patients with benign prostatic hyperplasia].
    Cao NL; Lu QJ; Wang XH; Ni JS; Gu BJ; Hu B
    Zhonghua Nan Ke Xue; 2017 Apr; 23(4):315-318. PubMed ID: 29714415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign prostatic hyperplasia: clinical benefits on Three-Dimensional Ultrasound eXtended Imaging (3D-XI).
    Elwagdy S; Samy E; Sayed M; Gamal AH
    Int J Urol; 2008 Apr; 15(4):332-9. PubMed ID: 18380823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suprapubic versus transrectal ultrasonography in assessing the volume of the prostate and the transition zone in patients with benign prostatic hyperplasia.
    Prassopoulos P; Charoulakis N; Anezinis P; Daskalopoulos G; Cranidis A; Gourtsoyiannis N
    Abdom Imaging; 1996; 21(1):75-7. PubMed ID: 8672981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transrectal ultrasound of the prostate].
    Ramírez-Arias JL; González-Roman A; Cal y Mayor-Villalobos M; Barreda-Reyes LM
    Gac Med Mex; 1991; 127(3):241-6; discussion 246-7. PubMed ID: 1724768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia: a review and ultrasound classification.
    Wasserman NF
    Radiol Clin North Am; 2006 Sep; 44(5):689-710, viii. PubMed ID: 17030221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Color Doppler sonography of the prostate.
    Miller SM; Ackermann R
    Urol Int; 1996; 57(3):158-64. PubMed ID: 8912444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.
    Berger AP; Deibl M; Halpern EJ; Lechleitner M; Bektic J; Horninger W; Fritsche G; Steiner H; Pelzer A; Bartsch G; Frauscher F
    Diabetologia; 2005 Apr; 48(4):784-9. PubMed ID: 15756540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Gormley GJ; Dorey FJ; Shery ED; Garris JB; Subong EN; Stoner E; deKernion JB
    J Urol; 1997 Jun; 157(6):2171-8. PubMed ID: 9146609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Tadalafil on prostate haemodynamics: preliminary evaluation with contrast-enhanced US.
    Bertolotto M; Trincia E; Zappetti R; Bernich R; Savoca G; Cova MA
    Radiol Med; 2009 Oct; 114(7):1106-14. PubMed ID: 19697101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endorectal ultrasound of the prostate].
    Chanis G; Chanis GD
    Rev Med Panama; 1993 May; 18(2):120-7. PubMed ID: 7687067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.